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Abstract  
 
 Breast cancer continues to remain a significant health issue for women. 
Previously thought to only occur among postmenopausal women, breast cancer has 
impacted women of different ages; and rates of breast cancer have various impacts 
among different ethnic groups. For women living in a toxic environment, many of them 
have become the new wave of breast cancer cases. Screening and detection have 
succeeded in decreasing mortality rates. However, more research is needed in finding 
an efficient method of treatment. In the effort to assist in the fight against breast cancer 
through a policy and programmatic angle, I am fulfilling my internship at Breast Cancer 
Prevention Partners. The organization has been active for 25 years engaging 
community members in the fight against breast cancer. In the Program & Policy 
Department, the work is centered around policy advocacy with regards to state and 
federal regulations that impact environmental exposures for women and children. The 
goal of the Campaign for Safe Cosmetics is to protect the health of consumers, workers, 
and the environment through public education and engagement, corporate 
accountability and sustainability campaigns, and legislative advocacy. This fieldwork 
placement resulted in the Breast Cancer Prevention Partners drafting a public comment 
to the FDA in response to their proposed lead maximum in lip cosmetics and external 
cosmetics. Due to the ever-changing political climate in Washington D.C., the second 
project did not come to pass. Anyone that is interested in this path must be cognizant of 
the impact of an unstable political climate.    
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I. Introduction 
 
Previously thought to only occur among post-menopausal women, breast cancer 
has impact women of different ages. Breast cancer has had various impacts among 
different ethnic groups. Years spent living in a toxic environment has created a new 
source of breast cancer cases. Despite the ample amount of evidence found in toxic 
exposure in rates of other types of cancer, my fieldwork intends to address and assist in 
filling the gap of environmental exposures and rates of breast cancer incidence, 
treatment, and mortality.  
This form of cancer has traditionally been believed to occur only among post-
menopausal women. However, through recent years we have seen a steady increase 
among pre-menopausal women in the development of various forms of breast cancer. 
Althuis et al. noticed a diverse range of causes in women less than 20 years of age 
being diagnosed with ER+ or PR+ breast cancer (Althuis, et al., 2003). Factors such as 
race, income level, oral contraceptive use, number of children, frequency of 
mammograms, time of menarche, and proxy of relative with breast cancer were all 
found to influence risk of developing breast cancer. Despite more research being 
needed, this study found African American women at a particularly higher risk of 
developing breast cancer regardless of age and contraceptive use, showing a relative 
risk for women age 20-24 years at 2.49 and 2.42 for women 45-54. As our society 
continues to progress in technological advancement, one needs to consider the 
increase in exposure for women younger than 20 years of age. We may begin to see a 
new trend of benign and aggressive cases of breast cancer among this group.  
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 Aside from this disease impacting different age groups, women of different ethnic 
groups are also unequally impacted. Between 2003 and 2012, the CDC determined that 
the incidence of breast cancer cases had remained level for White, American 
Indian/Alaska Native, and Hispanic women; while for African American/Black and 
Asian/Pacific Islander women the incidence rate increased by 0.8% and 1.1% per year 
respectively (Centers for Disease Control and Prevention , 2016). The mortality rates 
decreased among these ethnic groups, with the most significant difference being seen 
in American Indian/Alaska Native women and the least being seen among Hispanic 
women (Centers for Disease Control and Prevention , 2016). Sociodemographic factors 
ranging from income and education status, to ethnicity and age have all influenced the 
diagnosis, treatment, and survival rate.  
It is easy for a medical professional to tell the patient to change their lifestyle to 
reduce the risk of developing breast cancer; however, not considering the possible 
barriers that may impede any progress is detrimental to the most vulnerable 
populations. For example, in 2016 Smith et al. assessed the impact of high BMI among 
African American women with rates of breast cancer recurrence. The analysis found 
African American women with a BMI higher than 30kg/M were experiencing breast 
cancer recurrence more often than women who could lower their BMI. This finding did 
not coincide with survival rates, however women who were able to achieve a “healthier 
weight” by following through on the diet recommendations by their doctors had a 
successful rate of remission. Also, women who were categorized as obese were more 
often diagnosed with late stage breast cancer (types IIIA, IIIB, and IV) (Smith, et al., 
2016). By not considering the barriers patients may encounter in attempting to follow 
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medical recommendations such as living in a food desert where access to fruits and 
vegetables is extremely rare; incidence and mortality rates among vulnerable groups 
such as African American women with a high BMI will only increase.  
Frequencies of gene expressions in certain subtypes of breast cancer have also 
impacted the rates of survival. Ma et al. analyzed the expression of the p53 gene in 
White, Hispanic, and African American women. Despite this gene arising in all three 
groups, the expression in African American women lead to a significant impact on 
mortality rates. His study found that African American women were more than likely to 
die from breast cancer despite the various forms of treatment (Ma, et al., 2013). 
Through variations in race, it is easy to simply assume that because a woman is African 
American that she is more than likely to not survive from breast cancer. However, other 
causes such as environmental exposure need to be considered.  
Years spent living and working in a toxic environment has created a new source 
of breast cancer cases. Women living on Cape Cod were found to have an increased 
risk of breast cancer. In 2004 McKelvey et al. found that women who had lived on Cape 
Cod for at least 5 years or more were at a higher risk of developing breast cancer. 
Social determinant factors such SES, ethnicity, education, parity, age of menopause, 
and proxy relative were all taken into consideration (McKelvey, Brody, Aschengrau, & 
Swartz, 2004). Due to the historical use of pesticides such as DDT, the rates of cases 
associated with women who lived in the area for 5+ years, the study highlights the ever-
increasing impact of environmental exposure on diagnosis. In 2007 Cohn et al. 
analyzed DDT exposure and breast cancer risk among women during the 1940’s. 
Investigators calculated the rate of exposure from the age of breast cancer diagnosis to 
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the age when health data was collected. Despite that many of the women involved did 
not reach the age of 50 when this study was conducted, the scientist still revealed very 
interesting results. The results indicated that high levels of exposure predicted a 
significant 5-fold increased risk of breast cancer among women that were born after 
1931; meaning they were under the age of 14 while DDT was widely used (Cohn, Wolff, 
Cirillo, & Sholtz, 2007). In 2012, the National Institute of Occupational Safety and Health 
found that women working in the garment industry were at risk of developing myeloid 
leukemia from persistent formaldehyde exposure. The more time spent in this industry 
increased the risk of diagnosis (The National Institute for Occupational Safety and 
Health (NIOSH), 2012). Despite the ample amount of evidence of environmental 
exposure and cancer rates, there is very little information on the impact of toxic 
exposure and breast cancer rates. My work with the Breast Cancer Fund is aimed at 
filling this gap. Through my time with this organization, I intend to assist in finding and 
spreading information related to toxic exposure in cosmetic & cleaning products.  
Traditionally classified as a disease that impacts women of certain ages and 
ethnic groups, this disease has begun to impact women of all ages and races. Factors 
such as SES, BMI and educational status continue to be analyzed as causes in 
variation of incidence and mortality. However, very little information has explained the 
impact of environmental exposures from residence to occupation. It is this area of 
causation in which my work intends to address.  
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II. Background 
 
Over the years, a lot of work has been put into the fight against breast cancer. 
There has been an emergence of new screening and detection methods. Although there 
has been success in finding new methods of treatment and detection, more research is 
needed. Using post-treatment methods such as breast reconstruction, the efficacy and 
use has been called into question. Lastly, with these advancements there are many 
areas that have not been effectively addressed.  
The emergence of screening and detection has succeeded in decreasing overall 
mortality rates. Wellings et al. compared the value of an MRI to that of a mammogram. 
The use of mammograms has been contested with the promotion of an MRI for high risk 
breast cancer patients. This review looks at the studies on rates of detection and cost-
effectiveness of an MRI and mammogram. For women with less dense breast tissue, 
the mammogram is recommended as lesions are easily detected. However, women that 
carry the BRCA1 or BRCA2 gene tend to have very dense breast tissue and are usually 
diagnosed with more aggressive strains of breast cancer. It has been recommended 
that doctors use an MRI as a standard method of screening & detection. The only issue 
that has not been addressed is whether women in older age groups should go through a 
mammogram as well as an MRI. The argument is that despite the MRI being more cost 
effective, it is an unnecessary method as older women tend to have less dense breast 
tissue (Wellings, Vassiliades, & Abdalla, 2016). In 2006, Plevritis and his colleagues 
analyzed the cost effectives of an MRI for women with the BRCA1 and BRCA2 gene. 
According to Plevritis et al., women that carry the BRCA1 gene will benefit more from an 
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MRI than a mammogram. Considering different age groups and variations of BRCA1 
and BRCA2 gene expression; it was found that women with the BRCA1 gene between 
that ages of 45 and 65 would benefit the most from using an MRI. Despite the increase 
in cost and the high rate of false-positives, this method of detection was found to 
increase life expectancy (Plevritis, et al., 2006).  
In addition to different methods of detection, the use of a mastectomy as a 
preventative measure among women with a higher risk has been analyzed. Collins and 
his colleagues found that the use of risk reducing mastectomy and other preventive 
surgical methods was found to be beneficial in decreasing the incidence of breast 
cancer among women 45 years of age and older. The drawbacks from this method stem 
from complications during and after surgery, ranging from infection at the surgical 
incision to body image concerns (Collins, et al., 2013).  Despite the emergence of 
screening and detection methods more research is needed in finding an efficient 
method of treatment. Earlier this year, Yu et al. analyzed how the Star-PAP protein may 
be the next step in breast cancer treatment. The scientists in this study found that the 
Star-PAP protein plays a vital role in the development of tumor cells, but it is also 
viewed as a possible suppressant. Tested through a handful of trials with databases 
from all over China, this protein was found to influence the mitochondrial death of a 
tumor cell. Through this, scientists have determined that targeting this protein via the 
TUT1 gene during chemotherapy will improve the effects of treatment (Yu, et al., 2017).   
Within the sphere of chemotherapy, there have been new findings in the use of 
chemotherapy among different ethnic groups, as well as advancements in alternative 
forms of treatment. Earlier this year Sheppard and colleagues noticed a wide variation 
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in the rates of triple negative breast cancer and the use of chemotherapy among Black 
and White women. The study found that women diagnosed with triple negative breast 
cancer TNBC were more likely to be Black than White. As a result, the use of 
chemotherapy was higher among Black women (Sheppard, et al., 2017). Despite the 
increase in use of chemo among Black women the completion rate of chemotherapy 
was higher among White patients. Also, women from both ethnic groups were found to 
lower the use of chemo as their age increased. Scientists in this study guessed the 
reason behind the disparities to be healthcare discrimination, age at diagnosis, and 
stage of breast cancer. Women diagnosed with late stages (IIA, IIB, and IV) were less 
likely to opt for chemo and happened to be at an older age (Sheppard, et al., 2017). 
Also, earlier this year, Suryawanshi and her colleagues analyzed the efficacy of 
oncolytic viruses (OV)as an option for breast cancer treatment. Like the mechanism of a 
vaccine, the OV was found to attack the growth and replication process of the tumor cell 
without the added toxic exposure risk of chemotherapy (Suryawanshi, Zhang, & Essani, 
2017). Used as a single form of treatment, the oncolytic virus was not effective in 
treating patients compared to chemotherapy. However, when used with other forms of 
treatment such as chemo the virus showed a more successful result in treating patients 
particularly one with invasive breast cancer. The primary concern of this use is 
possibility of mutation and the mutation becoming ineffective in treatment, whether in 
monotherapy or combination therapy (Suryawanshi, Zhang, & Essani, 2017). 
Common practices in remission have called into question of what it means to be 
a woman. The use of reconstructive surgery methods has become important in breast 
cancer recovery. However, the benefits are varied among different groups. The trend of 
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breast reconstruction after a mastectomy has increased over the years. Ilonza et al., 
analyzed the trends, different types of reconstruction, and the risks associated with 
each. Out of all the different methods, the TRAM flap reconstruction carried the highest 
risk of developing complications after surgery. The most popular and safer option was 
the tissue expander (TE) method (Ilonzo, Tsang, Tsantes, Estabrook, & Thu Ma, 2017). 
Though the TE method, women can continue cancer treatment immediate after surgery. 
The study involved 67,450 patients through the National Surgical Quality Improvement 
Program (NSQIP) database, and were followed from 2005 to 2014 (Ilonzo, Tsang, 
Tsantes, Estabrook, & Thu Ma, 2017). External factors such as race, age, 
socioeconomic status (SES), neurological state, and comorbidities were taken into 
consideration. Despite African American women carrying the highest number of cancer 
cases, they were least likely to undergo reconstruction after a mastectomy despite the 
increase in procedure. Also in this study, older women were less likely to undergo 
surgery while women 40 years and younger consisted of the largest portion of patients.  
Aside from analyzing patient use of reconstructive surgery, medical professionals 
were also surveyed. Earlier this year Coroneos and colleagues interviewed medical 
professionals on their perspective of breast cancer reconstruction. The results of this 
survey indicated that surgeons, oncologists, and plastic surgeons agreed on the 
drawbacks of reconstructive surgery, specifically implant based reconstruction (IRB) 
(Coroneos, et al., 2017). The delay in future treatment due to time spent in recovery 
was found to increase the risk of additional tumors. Also, the IRB method of 
reconstruction interfered with detection methods thus further increasing the patients risk 
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of new tumors. The primary reason behind the issues of IRB was the lack of resources 
from the national health department (Coroneos, et al., 2017).  
Despite the advancements in breast cancer research, screening, and treatment 
there is more work to be done. Laws and regulations on environmental & toxic 
exposures has been one of the areas in need of more information. My time spent at the 
Breast Cancer Fund focuses on the impact of environmental health regulation on the 
state & federal level, research, and common preventative measures.  
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III. Scope of Work  
 
In the effort to participate in the fight against breast cancer through a policy and 
programmatic angle, I am fulfilling my internship requirement at Breast Cancer 
Prevention Partners, formerly known as the Breast Cancer Fund in San Francisco, CA. 
My work is housed primarily in the Program & Policy department, with some work in the 
Science & Research department. The target population for both departments and the 
organization is primarily women of reproductive and post reproductive age, and young 
girls. Breast Cancer Prevention Partners targets consumers that are exposed to any 
toxic chemicals that are linked to cancer and other long term health effects. BCPP 
targets women and children of all ethnic groups and income levels that are exposed to 
toxic chemicals linked to cancer and other long term effects. The geographic scope of 
the organization is primarily within the state of California, however the joint efforts 
through the Campaign for Safe Cosmetics serve women and children all over this 
country. Despite being a national 501(c)3 organization, most staffers reside in San 
Francisco with 17 men and women located in the main office, and three groups located 
in CA and Washington DC serving as consultants and lobby groups. For my internship, I 
was assigned two projects in two different departments aimed to strengthen the CSC 
Business Network and successfully advocate for the CA Fragrance Disclosure Bill to 
complete the implementation of the 2017 product testing initiative.  
The organization has been active for 25 years engaging community members 
locally and nationally in the fight against breast cancer. The mission of this organization 
is to work to prevent breast cancer through eliminating the exposure to toxic chemicals 
and radiation that is linked to the disease (The Breast Cancer Fund, 2016). They 
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translate the growing body of scientific evidence linking breast cancer and 
environmental exposures into public education and advocacy campaigns that protect 
our health and reduce breast cancer risk. Also, the organization looks for practical 
solutions so that future generations can thrive (The Breast Cancer Fund , 2015).  
In Program & Policy, the work is centered around policy advocacy with regards to 
state and federal regulations that impact environmental exposure for women and 
children. Also, this department is the home of the Campaign for Safe Cosmetics. This 
campaign works on market based work with small and large cosmetic and personal care 
businesses in assisting political advocacy through being an example of a successful 
green product manufacturer. The Science department is responsible for the annual 
product testing, which tests some of the most common cosmetic, personal care, and 
cleaning products on the market for toxic chemicals. Each year the hazardous chemical 
in question is selected based off the proposed or supported state/federal legislation. 
This year, the focus is on fragrances which has been known to cover hundreds of 
harmful chemicals which are not reported by the businesses or manufacturers. Also, 
this department is responsible for maintaining the accuracy of data in every study 
conducted by Breast Cancer Prevention Partners.    
 
Program and Policy Department 
 The Program and Policy Department is responsible for all programmatic and 
policy work of Breast Cancer Prevention Partners. The work is divided amongst two 
groups, the Program Team (with the consultation of Science Team), and the Policy 
Team. The policy team works to develop, advocate for, and evaluate proposed and 
current policies at the local, state and federal levels as they relate to environmental 
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health, chemical regulation and exposure, and consumer right to know. The goal of the 
policy team is to support health protective policies that reduce exposure to toxic 
chemicals. The program team is responsible for managing two market-based 
campaigns, the Campaign for Safe Cosmetics and Cans Not Cancer. These campaigns 
include market-based advocacy in addition to legislative advocacy. The goals of the 
Campaign for Safe Cosmetics are the same for Cans Not Cancer.  
 The goals for the project I am working on are to successfully advocate for the CA 
Fragrance Bill and to complete the implementation of the 2017 Product Testing 
initiative. The goals for my work within this project are the following, understanding how 
market-based campaigns support state and federal policy initiatives and how market 
campaigns are executed; understand current state and federal regulations on ingredient 
disclosures in cosmetics and cleaning products; and to engage in strategic planning for 
state and federal legislation related to fragrance disclosure. Looking at the ecological 
model the organizational, community, and societal levels are involved in the first goal. 
All three levels are addressed through my research which will focus on current and 
previous campaigns on the county, state, and federal level. For the second goal, the 
only ecological model level addressed is societal. Here I will be researching current 
state and federal regulations on ingredient disclosures that will impact the U.S. and 
influence international regulations. Like the first goal, the societal, community, and 
organizational levels are addressed in the final goal. All three levels will be addressed 
through my participation in meetings involving local and national organizations on state 
and federal efforts. The site and players involved on all three goals are the Breast 
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Cancer Prevention Partners, the Senior Policy Coordinator, the Director of Program & 
Policy, and the Program and Outreach Manager.  
 My role in this project is under the same title of Program & Policy Intern. I am 
providing support for the previously mentioned players involved. The activities I will be 
doing are the following, assist the Science Department with chemical research on 
California and Washington state databases to inform product testing; mapping potential 
disclosure laws nationwide; participate in organizational strategic planning; participate 
and support steering committee and other coalition convenings related to cosmetics 
legislations. I will be assisting the product testing project through researching California, 
Washington, and international databases for chemicals that are classified as a 
fragrance. Once identified it is my job to research the health risks of each chemical. The 
next two activities will occur through qualitative research on previous and current 
legislation regarding fragrance disclosure laws and assessing the communications of 
the organization with federal agencies such as the FDA. For the last activity, I will be 
monitoring the progress of the proposed Affordable Care Act repeal & replacement bills; 
and I will be monitoring the progress regarding the dismantling of the EPA. The 
projected outcomes of the activities are the following, a completed research excel sheet 
of chemicals in fragrances; a summary document of federal and state disclosure 
regulations and potential new legislations; and a completed draft of a public comment to 
the FDA’s Lip Cosmetics & External Cosmetic Lead Level Industry Guidance.  
 Through the immense and complex amount of work being done at Breast Cancer 
Prevention Partners, it is with great hope that we will be one step closer to preventing 
future loss from breast cancer. It is through this organization that the intention to assist 
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researchers and medical professionals through making a difference in the impact of 
breast cancer on the most vulnerable populations will yield a successful result.   
 
Campaign for Safe Cosmetics 
 The goal of the Campaign for Safe Cosmetics (CSC) is to protect the health of 
consumers, workers, and the environment through public education and engagement, 
corporate accountability and sustainability campaigns and legislative advocacy 
designed to eliminate dangerous chemicals linked to adverse health impacts from 
cosmetics and personal care products (Campaign for Safe Cosmetics, 2017). The CSC 
Business Network is a collaborative of retailers, manufacturers, formulators, business 
owners and other members of the cosmetics and personal care products industry that 
support the mission and goals of the Campaign for Safe Cosmetics. The goals of the 
business network are to, stimulate the innovation of safe, non-toxic personal care 
products that the world market is demanding; protect consumers, workers and the 
environment from exposure to chemicals linked to cancer, reproductive harm and other 
adverse health impacts; and to ensure everyone in the U.S. has access to safe personal 
care products, regardless of geography and income (Campaign for Safe Cosmetics, 
2017).  
  In this project, my objectives are to learn the best practices for communication 
with current and potential business network members; develop an orientation 
onboarding process and toolkit for CSC business network members; and to understand 
the strategy and process around rebuilding the coalition of endorsing organizations. In 
the first objective, the parent organization Breast Cancer Prevention Partners, the 
Program Director, and the Program Outreach Manager are involved in supervising my 
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work. On the ecological model my work involves the following levels individual, 
interpersonal, organizational, and community. For the individual and interpersonal 
levels, I will be learning how to create an orientation pamphlet and I will learn how to 
develop an onboarding process through communicating and shadowing with the 
department director and the Program & Outreach Manager. The community and 
organizational levels will be accomplished through the implementation of the orientation 
packet and onboarding process with the toolkit. I will be the point of contact for business 
owners, retailers, and other organizations regarding inquiries of new initiatives and 
meetings spear headed by the campaign. Through this objective, I will be shadowing my 
supervisors in how they communicate with members and facilitate the orientation all-
calls. In the last objective, the previously stated players and site will be involved.  
 My role as the program and policy intern is to provide support for the director of 
the Program and Policy Department and the Program & Outreach Manager. The 
internship responsibilities are as follows, manage communication with the CSC 
business network; respond to inquiries and other messages from the business 
community; develop an onboarding process; develop orientation materials; develop a 
blogger network within CSC; and provide outreach to current and new coalition 
members. The first two activities will take place through monitoring the CSC business 
network email daily. The onboarding process and orientation materials will be done 
through consolidating the many contact lists, and attending the monthly orientation 
phone calls. Developing a blogger network and providing outreach to current and new 
coalition members, will take place through updating the contact list of business network 
members. The outcomes of my activities are as follows, an updated “Master List” of 
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CSC coalition members; a creation of orientation and onboarding materials; an 
established blogger network and a set of processes to support the network; and the 
creation of outreach communication materials. The intended audience for these 
outcomes are the consumers of personal care and cleaning products whom are at risk 
of developing cancer from exposure to toxic chemicals.  
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IV. Public/Population Health Impact: Findings and Significance 
 
 This fieldwork placement resulted in Breast Cancer Prevention Partners drafting 
a public comment to the FDA in response to their proposed lead maximum in lip 
cosmetics and external cosmetics. Another result of this fieldwork placement is the 
creation of an onboarding toolkit for new businesses and new endorsing organizations 
to the Campaign for Safe Cosmetics Business Network. The FDA public comment 
revealed a lot of information regarding the loopholes in federal regulation for cosmetic 
companies. However, more work is needed to accomplish the goal of erasing toxic 
ingredients from cosmetic products. Due to the transition to the Trump Administration 
and the ever-changing political climate in Washington, the onboarding toolkit for the 
program did not come to pass.  
 
Policy Project Outcome  
The first outcome of my time with Breast Cancer Prevention Partners was the 
public comment drafted by the organization to the FDA in response to its “Lead in Lip 
Cosmetics & External Cosmetics Draft Guidance.” The first finding from this result was 
the permissible concentration level of toxic chemicals like lead that were present in high 
priced and affordable lip & external cosmetic products. The recommended maximum 
level for the cosmetic industry drafted by the FDA was 10 ppm. My research on 
permissible levels of lead in cosmetic products indicated that the international 
community has not only a lower maximum level but also indicate that no level of lead is 
safe. Due to my research on studies regarding the rate of ingestion and the health 
impact; my finding which was stated in the public comment suggested a lower maximum 
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level to that of 0.02ppm. In addition, through analyzing the instances of communication 
between the FDA and BCPP I noticed that any studies conducted by the organization or 
any of their partners were found insufficient by the federal agency. As required work 
prior to drafting the public comment, I read the supplemental information provided by 
the FDA which included their studies and results justifying the proposed maximum level. 
Despite the ample amount of evidence from their four studies, none of them considered 
the health impact of ingesting lead from lip cosmetics and external cosmetics.  
The second finding from this result was the difficulty in manufacturing naturally 
derived products at a low cost. Through my research, I found that cosmetic companies 
that used naturally derived ingredients in their products had to price their stock at a 
higher amount due to federal regulation allowing synthetic and often harmful chemicals 
to be used at a lower cost. Thus, women of low socioeconomic status were unable to 
decrease their level of risk due to the high price of safer products.  
 
Campaign for Safe Cosmetics Outcome 
 Due to efforts by the Trump Administration to defund the Environmental 
Protection Agency and to replace the Affordable Care Act, the onboarding tool kit for 
new business members was not developed.  The finding from this result was the 
influence of politics in Washington D.C. on the work of nonprofit organizations. Due to 
the influence of federal funds for program initiatives, anyone who chooses to venture 
into this line of work will need to be aware of how changes in Washington will shift the 
organization’s initiatives and efforts.  
 
 
Policy Next Steps 
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 The FDA public comment revealed a lot of information regarding the loopholes in 
federal regulation for cosmetic companies. However, more work is needed to 
accomplish the goal of erasing toxic ingredients from cosmetic products.  
 More research is needed in finding out how toxic chemicals like lead in cosmetic 
products impact the risk of endocrine disruption, specifically for young women and girls. 
The findings from the supporting studies along with trials conducted by the FDA prove 
that more search is needed into the long-term health impact of lead exposure through 
lipstick and external cosmetic use. Also, research is needed on assessing the health 
impact on women of low SES as many toxic free products are unaffordable.  
 One program next step is the opportunity to develop an educational program for 
elementary and middle school students on the harmful effects of toxic chemicals in 
makeup. This program can go into schools and/or partner with after school programs to 
conduct education workshops showing what toxic chemicals are in our makeup and 
personal care products. The end goals of this program are to have the students 
remember to read the product label, and to successfully remember the names of the 
“toxic trio” which are Formaldehyde, Dibutyl Phthalate (DBP), and Toluene.  
 On the policy level, more regulation is needed in reducing the use of toxic 
chemicals like lead in cosmetic products. Closing the loopholes and increasing federal & 
international oversight will assist in decreasing the presence of these harmful chemicals 
in cosmetic products. Second, the advocacy of the European model of precautionary 
testing before an item is placed on the market will be substantial in decreasing exposure 
risk. Lastly, creating a policy that advocates for naturally derived chemicals in 
replacement of synthetic ingredients, and creating a tax break for companies that use 
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toxic-free ingredients; will assist in decreasing the price of eco-friendly cosmetics thus 
giving women and girls of low SES the opportunity to decrease their risk of toxic 
chemical exposure. Creating an incentive for companies will encourage more 
manufacturers and thus the cosmetic industry to consider using cleaner ingredients in 
all their personal care products. 
 Drafting the public comment on behalf of Breast Cancer Prevention Partners 
exposed me to the numerous discrepancies and nuances of the federal government. To 
many, the thought of federal oversight is an unwelcomed idea. However, through this 
process I have learned that advocating for policy changes that assist in easier access to 
healthier products helps in reducing the risk of breast cancer among the most 
vulnerable groups such as minorities and women of low socioeconomic status. Despite 
the inability to create the toolkit for new businesses joining the Campaign for Safe 
Cosmetics; I experienced the level of vulnerability that many organizations and health 
entities deal with in response to shifting changes in Washington D.C.   
 
Program Next Steps  
 Working with an organization that is rooted in environmental health for women 
with breast cancer and for those at risk on the policy advocacy level; the outcomes 
stemming from Capitol Hill have had an immense impact on the work being done. For 
anyone that chooses to take on this type of work, I recommend that one remains vigilant 
to what is happening not only the state but federal level. Paying close attention to 
federal agencies like the EPA, FDA, and Energy & Commerce will be extremely helpful 
in circumnavigating any future obstacles.  
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V. Conclusion 
Over the years, breast cancer has continued to remain a significant health 
problem for women. The rates of breast cancer have varied among women of all ages 
and ethnic groups. Evidence has also been found sourcing toxic environmental 
exposures as the possible cause. A lot of work has been put into the fight against breast 
cancer. There have been different methods of treatment; however, despite the 
advancements, there is more work to be done.  
Breast Cancer Prevention Partners, formerly known as the Breast Cancer Fund 
has been in the fight against breast cancer for 25 years. Their mission is to connect the 
dots between breast cancer research and exposure to chemicals & radiation in our 
everyday environments (The Breast Cancer Fund, 2016). Their target population is 
consumers that are exposed to chemicals linked to cancer and other long term health 
effects.  
 The work at Breast Cancer Prevention Partners focused on assisting the 
rebuilding & strengthening of the Campaign for Safe Cosmetics Coalition (CSC). Also, 
my work focused on advocating, developing, and evaluating proposed & current policies 
at the local, state and federal level as they relate to environmental health, chemical 
regulation & exposure, and consumer right to know (Campaign for Safe Cosmetics, 
2017).  
The outcome of the internship at Breast Cancer Prevention Partners was a public 
comment in response to the FDA’s Draft Industry Guidance on Lead in Lip Cosmetics 
and External Cosmetics. Stemming from this result, more research is needed in finding 
out how toxic chemicals like lead in cosmetic products impact the risk of breast cancer. 
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There is also an opportunity to develop an educational program for elementary and 
middle school students on the harmful effects of toxic chemicals in makeup. Lastly, 
more regulation is needed in reducing the use of toxic chemicals like lead in cosmetic 
and personal care products. Closing the loopholes and increasing federal & 
international oversight will assist in decreasing the presence of these harmful 
chemicals.  
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Appendix A 
 
Overall Reflection 
 
 My time spent at Breast Cancer Prevention Partners was an immense time of 
growth. Being at the organization during the onset of the Trump administration was a 
powerful example of how the political climate in Washington D.C. can impact the work 
and livelihood of a group of women in San Francisco, CA. After coming to the 
internship with zero experience or interest in policy, I am leaving with a newfound 
respect and admiration for the role policy plays in every aspect of our lives. Through 
my time here I now have a renewed passion to continue work within a field I am not 
only passionate about but truly believe can uplift and sustain my community.  
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Appendix B 
 
Final Fieldwork Objectives 
 
 
 
Goal 1: Learn how campaigns are planned and built in relation to federal & state policy regarding Environmental Health 
Objectives (S) Activities Start/End Date Who is Responsible Tracking Measure 
Understand how 
market-based 
campaigns support 
state and federal policy 
initiatives; and how 
market campaigns are 
planned and executed 
 
Planning meetings for 
Unilever Day of Action 
 
Developing resources 
and materials for Day of 
Action 
 
(TBD) assist Science 
department with 
chemical research on CA 
and WA state databases 
to inform product 
testing 
 
(end)2/14/2017 
 
(end)2/14/2017 
 
 
 
(start)2/1/17 
 
Sara Schmidt 
 
Sara Schmidt 
 
 
Connie Engle 
 
Participation in 
meetings 
 
Development of 
materials 
 
Research will be 
completed 
 
Understand current 
state and federal 
regulations on 
ingredient disclosures 
in cosmetics and 
cleaning products 
 
Mapping of potential 
disclosure laws 
nationwide 
 
 
(start)3/3/2017 
 
Nancy Buermeyer, Sara 
Schmidt 
 
Summary document of 
federal and state 
disclosure regulations 
and potential new 
legislation 
 
Engage in strategic 
planning for state and 
federal legislation 
related to fragrance 
disclosure 
 
Participate in 
organizational strategic 
planning 
 
Participate and support 
steering committee and 
other coalition 
convenings related to 
cosmetics legislation 
(start)2/10/2017 
 
Sara Schmidt 
 
Participation in 
meetings 
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Goal 2: Assist in building and strengthening the Campaign for Safe Cosmetics coalition (CSC) 
Objectives (S) Activities Start/End Date Who is Responsible Tracking Measure 
Learn best practices for 
communication with 
current and potential 
business network 
members 
 
Manage communication 
with CSC business 
network 
 
Respond to inquiries 
and other messages 
from the business 
community 
 
1/6/2017 
 
 
 
1/10/2017 
 
Sara Schmidt 
 
 
 
Sara Schmidt 
 
Orientation to business 
network 
 
Ongoing email 
communication 
 
Develop orientation and 
onboarding process and 
toolkit for CSC business 
network 
 
Develop onboarding 
process 
 
Develop orientation 
materials 
 
2/16/2017 
 
 
2/17/2017 
 
Sara Schmidt 
 
 
Sara Schmidt 
 
Draft and final versions 
of onboarding and 
orientation materials 
 
Understand strategy 
and process around re-
building coalition of 
endorsing organizations 
 
Develop blogger 
network within CSC 
 
Outreach to current and 
new coalition members 
 
3/2/2017 
 
 
2/1/17 
 
Sara Schmidt 
 
 
Sara Schmidt 
 
Established blogger 
network and set of 
processes to support 
the network 
 
Outreach 
communication 
materials 
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Appendix C 
 
Master of Public Health Program FIELDWORK TIME LOG 
 
 
Student 
InIIInformat ion   
Student’s Name: Nandi Robinson 
 
Campus ID # 20355386 
 
Student’s Phone: 510-294-9274 
 
Student’s Email: nmrobinson@dons.usfca.edu 
Preceptor 
I n f o r m a t i o n   
Preceptor’s Name: Sara Schmidt 
 
Preceptor’s Title: Outreach & Organizing Manager  
 
Preceptor’s Phone: 415-744-4675 
 
Preceptor’s Email: sara@bcpp.org  
 
Organization: Breast Cancer Prevention Partners, formerly known as Breast Cancer Fund  
 
Student’s Start Date: January 3, 2017 
 
Student’s End Date: Hours/week: April 14, 2017: 20 hours   
 
Time Log for (Check One): 
 
_________________ Summer 2016 _____________________Fall 2016 
 
 
 
_____________X____ Spring 2017 _____________________Summer 2017 
 
 
 
 
 
Week Total # of Hours for Week Preceptor Initials 
   Jan 3- Jan 6 28  S.S. 
   Jan 9 – Jan 13 28  S.S. 
   Jan 17 – Jan 19 21  S.S. 
  Jan 24 – Jan 28  35  S.S. 
  Jan 31 – Feb 3  19  S.S. 
 Feb 7 – Feb 10   24  S.S. 
Feb 14 - Feb 17  20.25  S.S. 
 Feb 20 – Feb 24  20  S.S. 
 Feb 27 – Mar 4  22.5  S.S. 
 Mar 6 – Mar 11  29  S.S. 
Mar 13 – Mar 17  17  S.S. 
 Mar 20 – Mar 24  15  S.S. 
 Apr 3 – Apr 7   17  S.S. 
 Apr 10 – Apr 14   13   S.S.  
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Appendix D 
 
Student Evaluation of Field Experience 
 
 
Student  Information 
 
Student’s Name: Nandi Robinson 
 
Campus ID # 20355386 
Student’s Phone: 510-294-9274 Student’s Email: nmrobinson@dons.usfca.edu  
Preceptor  Information 
 
Preceptor’s Name: Sara Schmidt  
 
Preceptor’s Title: Program & Outreach Manager  
 
Preceptor’s Phone: 415-744-4675 
 
Preceptor’s Email: sara@bcpp.org  
Organization: Breast Cancer Prevention Partners  
Student’s Start Date: January 3, 2017 Student’s End Date: Hours/week: April 14, 2017: 20 hours  
 
 
 
Please use the following key to respond to the statements listed below. 
SA = Strongly Agree A  = Agree D = Disagree  SD = Strongly Disagree   N/A = Not Applicable 
My Field Experience…   
Contributed to the development of my specific career interests SA A D SD N/A 
 
 
Provided me with the opportunity to carry out my field learning objective activities 
 
 
SA 
 
 
A 
 
 
D 
 
 
SD 
 
 
N/A 
Provided the opportunity to use skills obtained in MPH classes SA A D SD N/A 
Required skills I did not have 
Please list:  
 
 
SA 
 
 
A 
 
 
D 
 
 
SD 
 
 
N/A 
Required skills I have but did not gain in the MPH program 
Please list:  
 
 
SA 
 
 
A 
 
 
D 
 
 
SD 
 
 
N/A 
Added new information and/or skills to my graduate education 
Please list: drafting a public comment/statement to a federal 
agency.  
 
 
SA 
 
 
A 
 
 
D 
 
 
SD 
 
 
N/A 
Challenged me to work at my highest level SA A D SD N/A 
Served as a valuable learning experience in public health practice SA A D SD N/A 
I would recommend this agency to others for future field experiences. Yes   NO  
My preceptor…  
Was valuable in enabling me to achieve my field learning objectives SA A D SD N/A 
Was accessible to me SA A D SD N/A 
 
Initiated communication relevant to my special assignment that he/she considered of 
interest to me 
 
 
SA 
 
 
A 
 
 
D 
 
 
SD 
 
 
N/A 
 
 
Initiated communication with me relevant to general functions of the agency 
 
 
SA 
 
 
A 
 
 
D 
 
 
SD 
 
 
N/A 
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2. Would you recommend this preceptor for future field experiences? Please explain. 
 
 X Yes  No  Unsure 
 
Sara was a great preceptor, she made sure I could work on projects or subjects that interested me. Her door was 
always open to questions and concerns. She was patient with me on every task I did.  
 
 
 
 
 
3. Please provide additional comments explaining any of your responses. 
 
 
I highly recommend anyone that is interested in the field of Breast Cancer research, environmental health, or policy 
advocacy to consider interning with this organization. Keep in mind, this internship is unpaid.  
 
 
 
 
 
 
 
 
 
4. Summary Report: All students are required to prepare a written summary of the 
field work to be submitted with this evaluation form. 
 
 
 
 
 
 
 
Nandi Makeda Robinson                                                                                                April 13, 2017 
Student Signature    Date 
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Appendix E 
 
MPH Program Competency Inventory 
USF MPH COMPETENCIES HOW MY PROJECT ACHEIVES THOSE 
COMPETENCIES  
Discuss multiple dimensions of the policy-
making process, including the roles of ethics 
and evidence  
The FDA Public Comment on Lead and 
Lipstick Industry Guidance addresses the ethics 
and evidence in policy and regulation 
development. Also, the evidence from the 
annual cleaning and personal care product 
testing conducted by the Breast Cancer Fund 
will assist the CA Fragrance Disclosure Bill 
which is backed by the organization. My role 
for both projects is to provide support through 
research of fragrance chemicals and to conduct 
a literature review of domestic and 
international policies & regulations.   
Evaluate policies for their impact on public 
health and health equity  
The FDA Public Comment I drafted evaluates 
previous domestic and international regulations 
on lead and other carcinogenic exposures in 
cosmetic products.  
Communicate audience-appropriate public 
health content, both in writing and through oral 
presentation  
I developed a template for the Campaign for 
Safe Cosmetics Business Network and 
Endorsing Organizations on drafting a public 
comment in support of BCPP policy advocacy. 
I will also be assisting the monthly orientation 
all-calls for CSC businesses which will provide 
members with up to date information 
pertaining to public health policy.  
Perform effectively on interprofessional teams  My project overlaps the Program, Policy, and 
Science Departments at the Breast Cancer 
Prevention Partners. From advocacy work on 
the Fragrance Disclosure Bill to the annual 
product testing, I am in correspondence with all 
three.  
 Apply systems thinking tools to a public health 
issue  
My work with the Program, Policy, and 
Science departments involve the interpersonal, 
organizational, community, and national levels. 
For the interpersonal and organizational levels, 
I am working for the Campaign for Safe 
Cosmetics and will be in correspondence with 
CSC business members regarding policy 
actions BCPP is involved in. The community 
and national levels are found in my 
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involvement with advocacy work for the 
Fragrance Disclosure Bill and through my 
work on the FDA Public Comment which 
received support from more than 150 
organizations representing 9 million people.  
Select communication strategies for different 
audiences and sectors  
I developed two public comment guides for 
Campaign for Safe Cosmetics Business 
Network Members and BCPP Partners. Each 
guide composed of a template of where to 
submit their comment, how to draft, and 
several talking points to use.  
